From Cancer Diagnosis to Advocacy: Sahar Paz Builds House of Paz
Jul 16, 2025 - 00:40:49
Radio and PodcastLive Radio & PodcastsBusiness
From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229
Join us as we talk to Nicole Sandford, CEO of Aspira Women’s Health. Aspira Women’s Health is a publicly traded women’s health diagnostics company whose suite of non-invasive ovarian cancer blood tests are helping ensure...
About This Episode
From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 is an episode from FemTech Focus by Dr. Brittany Barreto. Join us as we talk to Nicole Sandford, CEO of Aspira Women’s Health. Aspira Women’s...
Podcast
This episode belongs to FemTech Focus.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 28, 2024, 00:50:33 long, audio available.
Related Episodes
Continue listening to more episodes from FemTech Focus.
Sin Reglas: Redesigning Menopause for Women Across Latin America
Jul 2, 2025 - 00:53:41
Rita Health and the Rise of Data-Driven Fertility Empowerment
Jun 9, 2025 - 00:49:31
AnelleO: 3D Printing the Future of Vaginal Drug Delivery
May 21, 2025 - 00:50:01
Light Therapy for Vaginitis: Cern's Drug-Free Revolution with Dr. Melanie Santos
Apr 23, 2025 - 00:40:00
Law, AI, and Endometriosis: Akifa Khattak & Her Health AI
Apr 9, 2025 - 00:44:32
Sara, the HIPAA-Compliant Period Tracking App by Comma with Miller Morris
Mar 26, 2025 - 00:48:27
Questions About This Episode
What is From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 about?
Join us as we talk to Nicole Sandford, CEO of Aspira Women’s Health. Aspira Women’s Health is a publicly traded women’s health diagnostics company whose suite of non-invasive ovarian cancer blood tests are helping ensure women receive the best care. Nicole has an extensive background as a highly skilled operator and took the helm at Aspira in early 2022. In their conversation, Nicole and Brittany discuss the challenges unique to ovarian cancer detection and treatment, why Aspira’s products are so revolutionary, and how the company is going after endometriosis next. Remember to like, rate and
Where can I listen to From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229?
You can listen to From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 from?
From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 is an episode from FemTech Focus by Dr. Brittany Barreto.
How long is this episode?
This episode is 00:50:33 long.
When was this episode published?
This episode was published on Feb 28, 2024.
Can I save From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FemTech Focus?
Yes. This page shows related episodes from FemTech Focus when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229?
You can listen to From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229 is from FemTech Focus by Dr. Brittany Barreto.
What are the episode details?
Published Feb 28, 2024 and 00:50:33 long